Portal de Periódicos da CAPES

Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations

2012; Wiley; Volume: 89; Issue: 3 Linguagem: Inglês

10.1111/j.1600-0609.2012.01814.x

1600-0609

Tommaso Caravita, Massimo Offidani, Agostina Siniscalchi, Silvia Gentili, Patrizia Caraffa, Alessio Perrotti, Paolo de Fabritiis, Pietro Leoni,

Research on Leishmaniasis Studies

European Journal of HaematologyVolume 89, Issue 3 p. 276-277 Letter to the Editor Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations Tommaso Caravita, Corresponding Author Tommaso Caravita Ematologia Ospedale S. Eugenio – Università Tor Vergata, Roma, ItalyCorrespondence Tommaso Caravita, Divisione di Ematologia, Ospedale S. Eugenio – Università Tor Vergata, P.le dell'Umanesimo, 10, 00144 Roma, Italy. Tel: +390651008983; Fax: +390651002390; e-mail: [email protected]Search for more papers by this authorMassimo Offidani, Massimo Offidani Clinica di Ematologia Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, ItalySearch for more papers by this authorAgostina Siniscalchi, Agostina Siniscalchi Ematologia Ospedale S. Eugenio – Università Tor Vergata, Roma, ItalySearch for more papers by this authorSilvia Gentili, Silvia Gentili Clinica di Ematologia Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, ItalySearch for more papers by this authorPatrizia Caraffa, Patrizia Caraffa Clinica di Ematologia Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, ItalySearch for more papers by this authorAlessio Perrotti, Alessio Perrotti Ematologia Ospedale S. Eugenio – Università Tor Vergata, Roma, ItalySearch for more papers by this authorPaolo de Fabritiis, Paolo de Fabritiis Ematologia Ospedale S. Eugenio – Università Tor Vergata, Roma, ItalySearch for more papers by this authorPietro Leoni, Pietro Leoni Clinica di Ematologia Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, ItalySearch for more papers by this author Tommaso Caravita, Corresponding Author Tommaso Caravita Ematologia Ospedale S. Eugenio – Università Tor Vergata, Roma, ItalyCorrespondence Tommaso Caravita, Divisione di Ematologia, Ospedale S. Eugenio – Università Tor Vergata, P.le dell'Umanesimo, 10, 00144 Roma, Italy. Tel: +390651008983; Fax: +390651002390; e-mail: [email protected]Search for more papers by this authorMassimo Offidani, Massimo Offidani Clinica di Ematologia Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, ItalySearch for more papers by this authorAgostina Siniscalchi, Agostina Siniscalchi Ematologia Ospedale S. Eugenio – Università Tor Vergata, Roma, ItalySearch for more papers by this authorSilvia Gentili, Silvia Gentili Clinica di Ematologia Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, ItalySearch for more papers by this authorPatrizia Caraffa, Patrizia Caraffa Clinica di Ematologia Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, ItalySearch for more papers by this authorAlessio Perrotti, Alessio Perrotti Ematologia Ospedale S. Eugenio – Università Tor Vergata, Roma, ItalySearch for more papers by this authorPaolo de Fabritiis, Paolo de Fabritiis Ematologia Ospedale S. Eugenio – Università Tor Vergata, Roma, ItalySearch for more papers by this authorPietro Leoni, Pietro Leoni Clinica di Ematologia Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, ItalySearch for more papers by this author First published: 01 June 2012 https://doi.org/10.1111/j.1600-0609.2012.01814.xCitations: 11Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Quach H, Ritchie D, Stewart AK, Neeson P, Harrison S, Smyth MJ, Prince HM. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myelomaImmunomodulatory drugs in Myeloma. Leukemia 2010; 24: 22–32. 2Dimopoulos MA, Palumbo A, Attal M, et al. Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement. Leukemia 2011; 25: 749–60. 3Palumbo A, Mateos MV, Bringhen S, San Miguel JF. Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients? Blood Rev 2011; 25: 181–91. 4Nucci M, Anaissie E. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 2009; 49: 1211–25. 5Offidani M, Corvatta L, Polloni C, et al.Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide. Leuk Lymphoma 2011; 52: 776–85. Citing Literature Volume89, Issue3September 2012Pages 276-277 ReferencesRelatedInformation